Related Experiment Video

Updated: Jun 10, 2026

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
07:22

The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)

Published on: January 12, 2024

Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor

Christoph Klenk1, Thorsten Vetter, Alexander Zürn

  • 1Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany.

The Journal of Biological Chemistry
|July 27, 2010
PubMed

Insights

Na+/H+ exchange regulatory factor 1 (NHERF1) acts as an adaptor protein, facilitating beta-arrestin2 recruitment to the parathyroid hormone receptor type 1 (PTHR) through a phosphorylation-independent mechanism.

Area of Science:

  • Cellular Biology
  • Molecular Pharmacology
  • Signal Transduction

Background:

  • Beta-arrestins (β-arrestins) are key regulators of G-protein coupled receptor (GPCR) signaling, desensitization, and internalization.
  • Traditionally, agonist-promoted receptor phosphorylation was considered essential for β-arrestin2 recruitment.
  • Emerging evidence points to phosphorylation-independent mechanisms in β-arrestin2 recruitment by GPCRs, with PDZ proteins like Na+/H+ exchange regulatory factors (NHERFs) playing a role.

Purpose of the Study:

  • To investigate the interplay among NHERF1, β-arrestin2, and the parathyroid hormone receptor type 1 (PTHR).
  • To elucidate the role of NHERF1 in β-arrestin2 recruitment to the PTHR, particularly concerning phosphorylation-independent pathways.

Main Methods:

  • Utilized a combination of imaging, biochemical, and biophysical techniques.
  • Employed fluorescence resonance energy transfer (FRET) studies to analyze protein-protein interaction kinetics.
  • Conducted experiments in cultured human embryonic kidney (HEK) cells and Chinese hamster ovary (CHO) cells.

Main Results:

  • NHERF1 and β-arrestin2 independently bind to the PTHR, forming a ternary complex.
  • NHERF1 exhibits constitutive interaction with the PTHR, while β-arrestin2 binding is enhanced upon receptor activation.
  • NHERF1 directly interacts with β-arrestin2, independent of the PTHR.
  • NHERF1 modulates the interaction kinetics between the PTHR and β-arrestin2.

Conclusions:

  • NHERF1 functions as an adaptor protein, promoting β-arrestin2 proximity to the activated PTHR.
  • This interaction facilitates phosphorylation-independent β-arrestin2 recruitment to the PTHR.
  • Suggests a novel mechanism for GPCR regulation involving NHERF scaffolding of β-arrestin2.

More Related Videos

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin11:17

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Published on: March 10, 2021

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: